Keros Therapeutics Inc. Price to FCF Ratio 2020–2026

PE Ratio PS Ratio Price to Book Price to FCF Net Worth

Price to free cash flow (P/FCF) ratio for Keros Therapeutics Inc. (KROS): market cap divided by trailing twelve-month free cash flow. As of March 31, 2026 it is 2.05.

From: 03/31/2020To: 03/31/2026

Stock Price

TTM Free Cash Flow

Price to FCF

Keros Therapeutics Inc. Price to FCF Ratio — FAQ

Keros Therapeutics Inc. (KROS) price to fcf ratio over the last 7 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see KROS's price to fcf ratio history?

The chart and table above show Keros Therapeutics Inc.'s price to fcf ratio by year and by quarter, including the growth rate.